Current Pharmacological Management in Juvenile HuntingtonTMs Disease ΠPLOS Currents Huntington Disease
نویسندگان
چکیده
Background: The clinical presentation of Juvenile Huntington’s Disease (JHD) can be very different from adult-onset HD with little evidence to guide symptomatic management. Aim: To survey the current use of pharmacological treatments for JHD. Methods: Patients were identified through the HD Association, Hospital Doctors and the European Huntington’s Disease Network REGISTRY study. Results: The most commonly prescribed agents were anti-psychotics (24/45), anti-depressants (17/45) and anti-parkinsonian medications (15/45). 5 patients were taking more than 8 medications. Conclusions: The most commonly prescribed group of medication was the anti-psychotic. Many patients were on multiple therapies, highlighting the need to rationalise medications.
منابع مشابه
Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of HuntingtonTMs Disease: Exercise, Adenosine Receptors and Ampakines ΠPLOS Currents Huntington Disease
In the R6/2 mouse model of Huntington’s disease (HD) we examined the effects of a number of behavioral and pharmacological manipulations aimed at rescuing the progressive loss of synaptic communication between cerebral cortex and striatum. Two cohorts of transgenic mice with ~110 and 210 CAG repeats were utilized. Exercise prevented the reduction in striatal mediumsized spiny neuron membrane ca...
متن کاملCharacterization of Striatal Neuronal Loss and Atrophy in the R6/2 Mouse Model of HuntingtonTMs Disease Œ PLOS Currents Huntington Disease
Striatal neuronal degeneration and loss is an important feature of human Huntington’s disease (HD). R6/2 HD mice recapitulate many features of human HD including striatal atrophy. While striatal neuronal atrophy and loss is reported in R6/2 HD mice the degree of neuronal loss and the characteristics of cell body atrophy are unclear. We used stereological approaches to estimate whole striatal ne...
متن کاملNovel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest HuntingtonTMs Disease Œ PLOS Currents Huntington Disease
Background: We investigated the use of a simple novel nut and bolt task in premanifest and manifest Huntington’s disease (HD) patients to detect and quantify motor impairments at all stages of the disease. Methods: Premanifest HD (n=24), manifest HD (n=27) and control (n=32) participants were asked to screw a nut onto a bolt in one direction, using three different sized bolts with their left an...
متن کاملProgressive Impairment of Lactate-based Gluconeogenesis in the HuntingtonTMs Disease Mouse Model R6/2 Œ PLOS Currents Huntington Disease
Huntington’s disease (HD) is a neurodegenerative illness, where selective neuronal loss in the brain caused by expression of mutant huntingtin protein leads to motor dysfunction and cognitive decline in addition to peripheral metabolic changes. In this study we confirm our previous observation of impairment of lactate-based hepatic gluconeogenesis in the transgenic HD mouse model R6/2 and deter...
متن کاملDeficits in a Simple Visual Go/No-go Discrimination Task in Two Mouse Models of HuntingtonTMs Disease Œ PLOS Currents Huntington Disease
Huntington’s disease (HD), a devastating neurodegenerative disorder caused by a CAG repeat expansion on the HTT gene located on chromosome 4, is associated with a characteristic pattern of progressive cognitive dysfunction known to involve early deficits in executive function. A modified Go/No-go successive discrimination task was designed to assess the type of online response control/executive...
متن کامل